<DOC>
	<DOCNO>NCT01650142</DOCNO>
	<brief_summary>Thanks investigator previous study investigator demonstrate influence modify gene phenotypic expression neurofibromatosis 1 ( Hum Mol Genet . 2009 ; 18 ( 15 ) :2768-78 ) . Indeed , analysis intra-and inter-family variability perform use investigator phenotype/genotype database demonstrate strong genetic component clinical feature . The investigator result suggest involvement genetic factor , relate NF1 gene , modifier . The objective project identify modifier involve variability clinical expression NF1 . The investigator focus particular variant involve development progression neurofibroma .</brief_summary>
	<brief_title>Modifying Genes Neurofibromatosis 1</brief_title>
	<detailed_description>Neurofibromatosis 1 ( NF1 ) rare autosomal dominant disorder incidence one birth 3000 . NF1 gene locate 17q11.2 . The penetrance near 100 % age 8 de novo mutation represent half case . The product NF1 gene neurofibromin , protein control cellular differentiation proliferation . Phenotypic expression variable even family . Neurofibromatosis 1 characterized café au lait spot , freckle fold , Lisch'nodules ( hamartomas iris ) multiple neurofibroma . Manifestations neurofibromatosis 1 pleiotropic , potentially severe unpredictable . Morbidity mortality associate neurofibromatosis 1 link complication , optic pathway glioma , neurofibromas spine peripheral nerve , learn disability , scoliosis bone abnormalities vasculopathy . The investigator already demonstrate existence modifier , gene modify phenotypic expression neurofibromatosis 1 ( Hum Mol Genet . 2009 ; 18 ( 15 ) :2768-78 ) . Indeed , quantitative analysis inter intrafamilial variability perform data investigator phenotype/genotype database show strong genetic component study clinical trait estimate heritability 44 45 % subcutaneous plexiform neurofibroma , 66 % small café au lait spot . The investigator also show NF1 gene minor effect phenotypic variability . The investigator result suggest implication gene non link NF1 gene . The identification variant call modifier phenotype possible thanks investigator vast collection patient statistical power . The aim present study identify human genome genetic variant evolve pattern frequent manifestation neurofibromatosis 1 , neurofibromas . The genetic association study adapt purpose . The investigator bank include present time 1099 patient 575 family genotype , phenotype DNA sample . The investigator include 450 index case around 1000 independent patient neurofibromatosis 1 get 90 % statistical power detect variant 30 % frequency general population effect odds ratio 2 studied trait . The investigator use Affymetrix® Genechips 6.0 cover well whole genome . Identification variant provide new comprehension pathophysiology new target treatment .</detailed_description>
	<mesh_term>Neurofibromatoses</mesh_term>
	<mesh_term>Neurofibroma</mesh_term>
	<mesh_term>Neurofibromatosis 1</mesh_term>
	<criteria>Aged 18 Patient neurofibromatosis 1 accord NIH criterion : Six café au lait macules 15 mm great diameter postpubertal individual Two neurofibroma type one plexiform neurofibroma Freckling axillary inguinal region ( Crowe´s sign ) Optic glioma Two Lisch nodule ( iris hamartoma ) A distinctive osseous lesion sphenoid dysplasia thin long bone cortex without pseudoarthrosis A firstdegree relative ( parent , sibling , offspring ) NF1 criteria The criterion meet individual two feature list present . Children ( &lt; 18 yearold ) One member family already include study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Neurofibromatosis 1</keyword>
	<keyword>Phenotype</keyword>
	<keyword>Modifiers</keyword>
</DOC>